Volume | 676,052 |
|
|||||
News | - | ||||||
Day High | 16.93 | Low High |
|||||
Day Low | 15.985 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Edgewise Therapeutics Inc | EWTX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
16.06 | 15.985 | 16.93 | 16.17 | 15.94 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
8,267 | 676,052 | US$ 16.33 | US$ 11,043,079 | - | 5.12 - 20.6899 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:20:01 | formt | 589 | US$ 16.17 | USD |
Edgewise Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.51B | 93.11M | - | 0 | -100.16M | -1.08 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Edgewise Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EWTX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 15.26 | 16.93 | 14.90 | 15.64 | 522,829 | 0.91 | 5.96% |
1 Month | 18.28 | 19.21 | 14.90 | 16.37 | 533,361 | -2.11 | -11.54% |
3 Months | 18.66 | 20.6899 | 14.90 | 17.20 | 728,264 | -2.49 | -13.34% |
6 Months | 6.67 | 20.6899 | 5.12 | 13.63 | 771,776 | 9.50 | 142.43% |
1 Year | 7.70 | 20.6899 | 5.12 | 12.44 | 479,921 | 8.47 | 110.00% |
3 Years | 27.52 | 30.495 | 5.12 | 12.93 | 313,070 | -11.35 | -41.24% |
5 Years | 27.00 | 40.49 | 5.12 | 13.28 | 311,204 | -10.83 | -40.11% |
Edgewise Therapeutics Description
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. |